Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial
Graeme MacLennan, Helen Bell‐Gorrod, Suzanne B. Evans, Marcus J. Drake et al.
Citations
17 citations
Journal
The Lancet
Topics
Urinary Bladder and Prostate Research
Field-Weighted Citation Impact (FWCI)
31.22
article
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial
Graeme MacLennan, Helen Bell‐Gorrod, Suzanne B. Evans, Marcus J. Drake, Nikki Cotterill, Suzanne Breeman, Andrew Gammie, Victoria Bell, David Cooper, Alyaa Mostafa, John Norrie, Rebecca Bruce, Simon Dixon, Mohamed Abdel‐Fattah, Preksha Machaiya Kuppanda, Christopher Reginald Chapple, Karen Guerrero, Karen Ward, Hashim Hashim, Ash Monga, Karen Brown, C. Kennedy
article en
17 citations
Abstract
No abstract available for this paper.
Publication Tag
The LancetVol. 405(10484)
Institutions
North Bristol NHS Trust (GB), University of Aberdeen (GB), NHS Greater Glasgow and Clyde (GB), Aberdeen Maternity Hospital (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), University Hospital Southampton NHS Foundation Trust (GB), University of Bristol (GB), Manchester University NHS Foundation Trust (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), University of Sheffield (GB), University of Edinburgh (GB)
Funders
National Institute for Health and Care Research, Health Technology Assessment Programme